British-Swedish drugmaker AstraZeneca said there is no scientific evidence to back claims that its coronavirus disease 2019 (Covid-19) vaccine, AZD1222, triggered blood clotting or pulmonary embolism.
It gave the assurance after several countries in the European Union suspended the use of AZD1222, which was co-developed with the University of Oxford, following reports of blood clotting among those who had been vaccinated.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.